Stereotactic Radiation Shows Ability to Significantly Extend Survival in Cancer Patients with Multiple Metastasis

Stereotactic Radiation Shows Ability to Significantly Extend Survival in Cancer Patients with Multiple Metastasis
Patients whose cancer returns at multiple sites after treatment — called oligometastatic cancer — are generally thought incurable, but a recent Phase 2 trial found that a highly precise form of radiation can significantly extend these patients’ lives if the spread shows small tumors, without diminishing life quality. The approach was tested in patients with

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *